This document is an authorization letter from Augmedics LTD, granting RF Exposure Lab (Jay Moulton) the authority to act on their behalf for applications to Timco Engineering, Inc. The letter confirms that Augmedics LTD is not subject to denial of federal benefits, including FCC benefits, as per Section 5301 of the Anti-Drug Abuse Act of 1988. It also states that no party involved in the application is subject to denial of federal benefits, as defined in 47 CFR 1.2002 (b).
Augmedics LTD attests that all information provided is true and accurate, subject to 2015, 47 CFR 2.911(d), and that they are the responsible party subject to 2015, 47 CFR 2.909(a). The authorization applies specifically to the product with FCC ID 2AR2O-R68OQ865S. The agency agreement expiration date is October 22, 2025. The letter is dated October 22, 2024, and is signed by Stuart Wolf on behalf of Augmedics LTD.
Array
(
[0] => Array
(
[url_sha] => a65f256efeb864f4d7a6e3833fe2c4661a33b3d6b7868a0da23a17ea94f4f72c
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8126892
[href_text] => Authorization Letter
[href_description] => Augmedics LTD R68OQ865S Open-Q 865 SOM 2AR2O-R68OQ865S 2AR2OR68OQ865S r68oq865s
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] => application/pdf
[http_filename] => GetApplicationAttachment.html?id=8126892
[http_size] => 196784
[file_sha256] => 85be5766740629305c7c81cdbb57cc8e66e289a0718748123ba66491308f7698
[domain] => document.fccid
)
[1] => Array
(
[url_sha] => d2cd8f295e03c816862456b2260146c37fd613d20b5f1aa62943b810d11e1f43
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8139070
[href_text] => Authorization Letter
[href_description] => Augmedics LTD R68OQ865S Open-Q 865 SOM 2AR2O-R68OQ865S 2AR2OR68OQ865S r68oq865s
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] => application/pdf
[http_filename] => GetApplicationAttachment.html?id=8139070
[http_size] => 196784
[file_sha256] => 85be5766740629305c7c81cdbb57cc8e66e289a0718748123ba66491308f7698
[domain] => document.fccid
)
[2] => Array
(
[url_sha] => 2e3b7988f280f63c1bf02618300f8cb886770dcb9d609e1359f2c2955d15e35a
[source] => fccid
[url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8139034
[href_text] => Authorization Letter
[href_description] => Augmedics LTD R68OQ865S Open-Q 865 SOM 2AR2O-R68OQ865S 2AR2OR68OQ865S r68oq865s
[http_status] => 200
[http_lastmod] => 0000-00-00 00:00:00
[http_contenttype] =>
[http_filename] => GetApplicationAttachment.html?id=8139034
[http_size] => 196784
[file_sha256] => 85be5766740629305c7c81cdbb57cc8e66e289a0718748123ba66491308f7698
[domain] => document.fccid
)
)
Array
(
[file_sha256] => 85be5766740629305c7c81cdbb57cc8e66e289a0718748123ba66491308f7698
[cleanFccId] => 2AR2OR68OQ865S
[title] => Authority to Act as Agent - Augmedics LTD
[description] => Authorization letter granting RF Exposure Lab (Jay Moulton) authority to act on behalf of Augmedics LTD for Timco Engineering applications.
[brand_name] => Augmedics
[keywords] => ["2AR2O-R68OQ865S", "R68OQ865S"]
[intro] =>
This document is an authorization letter from Augmedics LTD, granting RF Exposure Lab (Jay Moulton) the authority to act on their behalf for applications to Timco Engineering, Inc. The letter confirms that Augmedics LTD is not subject to denial of federal benefits, including FCC benefits, as per Section 5301 of the Anti-Drug Abuse Act of 1988. It also states that no party involved in the application is subject to denial of federal benefits, as defined in 47 CFR 1.2002 (b).
Augmedics LTD attests that all information provided is true and accurate, subject to 2015, 47 CFR 2.911(d), and that they are the responsible party subject to 2015, 47 CFR 2.909(a). The authorization applies specifically to the product with FCC ID 2AR2O-R68OQ865S. The agency agreement expiration date is October 22, 2025. The letter is dated October 22, 2024, and is signed by Stuart Wolf on behalf of Augmedics LTD.
)
Array
(
[0] => Array
(
[id] => 8126892
[file_sha256] =>
[applicationId] => mKY/W8dIu0KDssXlXbFQJA==
[description] => Authorization Letter
[shortTermConfidential] => No
[permanentConfidential] => No
[supercede] => No
[exhibitType] => Cover Letter(s)
[fileType] => Adobe Acrobat PDF
[displayType] => pdf
[fileSize] => 196786
[submissionDate] => 2025-03-18 00:00:00
[dateAvailable] => 2025-03-18 00:00:00
[creationDate] =>
[producer] =>
[modDate] =>
[title] =>
[creator] =>
[author] =>
[pages] =>
[realSize] =>
[html] => 0
[png] => 0
[txt] => 0
[version] => 1
[source] => 0
[fccId] => 2AR2O-R68OQ865S
[cleanFccId] => 2AR2OR68OQ865S
[exif] => 0
)
)